Angela Merkel stated ahead of Thursday’s critical EU summit that she believes that Germany should be ready to make far larger contributions to the EU budget and that extra funding should be provided in the spirit of solidarity but for…
Read more...
Gilead, the California-based biotech company has developed an anti-viral drug that some experts hope could stop the Covid-19 virus from replicating. The drug was originally developed for Ebola, but has never been approved. Gilead’s Remdesivir drug has shown early positive…
Read more...
Since the beginning of the Coronavirus crisis, we have been monitoring our investment portfolios and their underlying fund holdings. Due to the generally more cautious positions we have been taking within our portfolios over the past 18 months as the…
Read more...
The global lockdowns are creating a self-imposed recession for justifiable public health reasons but the human fall out from these lockdowns are very real with business failures, unemployment and debt levels rising. The lives versus livelihoods debate is no easy…
Read more...
Global equities dropped back yesterday with the UK and Europe loosing around 3%. However, overall stocks have risen recently with the US leading this charge. To give you some context to how sizeable this relative US rally has been, the…
Read more...
Health and economic data are being poured over in the pursuit of the correct policy decision to exit the UK lockdown successfully. This is a delicate balance between the current and near future heath of the nation and the near…
Read more...
We have for the past year held a heavy underweight position to European equities due to scepticism over the scale of fiscal spend that could be mustered to combat poor economic growth. It was expected that the coronavirus outbreak would…
Read more...
As Italian and Spanish new coronavirus case growth has slowed, sentiment has been buoyed, culminating in the US market’s 7% rally on Monday. Both countries represented the epicentre of the European impact and therefore are expected to be the first…
Read more...
There is a major debate raging over the balance between looking after the health of the public and looking after the health of the economy. Policy makers have weighed up the cost of a global recession and the virus death…
Read more...